Get Started

APRE

NASD Aprea Therapeutics, Inc.
Oct 25, 2026 · 1:46 PM ET EOD Market Closed

$0.5177 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.5177, $0.0284 below the day’s high of $0.5461

YTD change
-39.31%
vs 20-day SMA
-18.49%
vs 200-day SMA
-32.38%

Price ranges

Previous day
$0.4950 $0.5461
open $0.5267 close $0.5177
-$0.0090 (-1.71%)
Today
$0.4950 $0.5461
$0.5177
Past week
$0.5106 $0.6580
from $0.6176 now $0.5177
-$0.0999 (-16.18%)
Past month
$0.5106 $0.8200
from $0.7797 now $0.5177
-$0.2620 (-33.60%)
This year
$0.4950 $1.4900
from $0.8530 now $0.5177
-$0.3353 (-39.31%)

Price & Performance

-0.34 (-39.88%) / 6M

$0.4807$0.6595$0.8382$1.02Apr 27Jul 27Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $1,062.2000
  • APRE is down 39% since the beginning of the year
  • APRE is down 66% over the past 12 months
  • APRE is down 34% over the past 1 month
  • 1% of all APRE investors are betting against APRE

APRE reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -61.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.07
Earnings momentum +3.4% Quarterly EPS growth
Quarterly change +3.4%

Valuation

P/E ratio N/A
Enterprise value $-11539400.0
Beta 1.89

Balance sheet & scale

IncomeN/A
Revenue$-9228.0
Cash$41.2M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $27.4M

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $439.26 -1.79%
MRNA Moderna, Inc. $200.10 -1.25%
RVMD Revolution Medicines, Inc. $186.99 -0.37%
ROIV Roivant Sciences Ltd. $36.49 -2.56%
BNTX BioNTech SE Sponsored ADR $88.12 -1.73%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.